USFDA completes inspection at Zydus Lifesciences’ SEZ Onco Injectable manufacturing plant

28 Mar 2024 Evaluate

United States Food and Drug Administration (USFDA) has completed inspection at Zydus Lifesciences’ SEZ Onco Injectable manufacturing plant at Ahmedabad. This cGMP USFDA inspection was conducted from March 18 to March 27, 2024. The inspection closed with 4 observations. There were no Data Integrity related observations. The Company will closely work with the USFDA to address the observations.

Zydus Lifesciences (formerly known as Cadila Healthcare) is an India-based pharmaceutical company.

Zydus Lifesciences Share Price

948.20 -2.75 (-0.29%)
26-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1504.25
Dr. Reddys Lab 6263.70
Cipla 1406.25
Zydus Lifesciences 948.20
Lupin 1615.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.